Is procalcitonin a reliable marker for the diagnosis of infected pancreatic necrosis?

ANZ Journal of Surgery

Volumn 74, Issue 7, 2004, Pages 591-595

  Yonetci, Nadir ^a   Sungurtekin, Ugur ^a,c   Oruc, Nevin ^b   Yilmaz, Mustafa ^a   Sungurtekin, Hulya ^a   Kaleli, Ilknur ^a   Kaptanoglu, Bunyamin ^a   Yuce, Gul ^b   Ozutemiz, Omer ^b  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Cerulein; Pancreatic necrosis; Pancreatitis; Procalcitonin; Taurocholate

Indexed keywords

ACUTE PHASE PROTEIN; AMYLASE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CERULETIDE; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; EDEMA; EVALUATION; FEMALE; HISTOLOGY; HORMONE BLOOD LEVEL; INFECTION; NONHUMAN; PANCREAS NECROSIS; PANCREATITIS; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; NECROSIS; PANCREAS; PANCREATIC DISEASES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS;

EID: 3442899397     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2004.03059.x     Document Type: Article

References (30)

1. Beger H, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis. Gastroenterology 1986; 49: 433-8.
2. Baron T, Morgan D. Acute necrotizing pancreatitis. N. Engl. J. Med. 1999; 340: 1412-17.
3. Rau B, Pralle U, UhI W, Schoenberg MH, Beger HG. Management of sterile necrosis in instances of severe acute pancreatitis. J. Am. Coll. Surg. 1995; 181: 279-88.
4. Gerzof S, Banks P, Robbins A, Johnson W, Spechler S, Wetzner S. Early diagnosis of pancreatic infection by computed tomography-guided aspiration. Gastroenterology 1987; 93: 1315-20.
5. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832-40.
6. Banks PA. Acute and Chronic Pancreatitis. In: Feldman M, Sleisenger MH, eds. Gastrointestinal and Liver Disease. Philadelphia: W. B. Saunders, 1998; Chapter 48.
7. Buchler M, Malfertheiner P, Schadlich H, Nevalainen TJ, Friess H, Beger HG. Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 1989; 97: 1521-6.
8. Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am. J. Gastroenterol. 2002; 97: 1309-18.
9. Balcy C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit. Care 2003; 7: 85-90.
10. Müller CA, Uhl W, Printzen G et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000; 46: 233-8.
11. Pezzilli R, D'eril GVM, Labate AMM, Merlini G, Barakat B, Bosoni T. Serum amyloid A, procalcitonin and C-reactive protein in early assessment of severity of acute pancreatitis. Dig. Dis. Sci. 2000; 45: 1072-8.
12. Ferriere F. Procalcitonin a new marker for bacterial infections. Ann. Biol. Clin. 2000; 58: 49-59.
13. Bertsch T, Richter A, Hofheinz H, Böhm C, Hartel M, Aufenanger J. Prokalzitonin: Ein neuer Marker für die Akute-Phase-Reaktion bei akuter Pankreatitis. Langenbecks Arch. Chir. 1997; 382: 367-72.
14. Uhl W, Schrag H-J, Schmitter N et al. Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in rats. Gut 1997; 40: 386-92.
15. Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand. J. Gastroenterol. 1980; 15: 411-16.
16. Schoenberg MH, Buchler M, Gasper M et al. Oxygen free radicals in acute pancreatitis of the rat. Gut 1990; 31: 1138-43.
17. Spormann H, Sokolowski A, Letko G. Effect temporary ischemia upon development and histological patterns of acute pancreatitis in the rat. Path. Res. Pract. 1989; 184: 507-13.
18. Oberhoffer M, Stonans I, Russwurm S et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J. Lab. Clin. Med. 1999; 134: 49-55.
19. Dandona P, Nix D, Wilson MF. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 1994; 79: 1605-8.
20. Oezcueruemez M, Porsch Kunz D, Hardt PD et al. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig. Dis. Sci. 1998; 43: 1763-9.
21. Schwarz M, Thomsen J, Meyer H, Buchler MW, Beger HG. Frequency and time course of pancreatic and extrapancreatic bacterial infection in experimental acute pancreatitis in rats. Surgery 2000; 127: 427-32.
22. Heath D, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie C. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-5.
23. Viedma J, Perez-Mateo M, Dominguez J, Carballo F. Role of interleukin-6 in acute pancreatitis comparison with C-reactive protein and phospholipase A. Gut 1992; 33: 1264-7.
24. Dervenis C, Johnson CD, Bassi C et al. Diagnosis objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference. Int. J. Pancreatol. 1999; 25: 195-210.
25. deBeaux AC, Goldie AS, Ross JA et al. Serum concentration of inflammatory mediators related to organ failure with acute pancreatitis. Br. J. Surg. 1996; 83: 349-53.
26. Jacobs MI, Dagget WM, Civetta JM et al. Acute pancreatitis: Analysis of factors influencing survival. Ann. Surg. 1977; 185: 43-51.
27. Webber J, Fromm D. Assessment, diagnosis, and initial treatment. In: Howard J, Yashuo I, Ihse I, Prinz R, eds. Surgical Diseases of the Pancreas, 3rd edn. Baltimore: Williams & Wilkins, 1998; Chapter 21.
28. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47: 546-52.
29. Berney T, Gasche Y, Robert J et al. Morel P Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999; 18: 371-7.
30. Rau B, Steinbach G, Meyer J et al. The role of interleukin-8 in the severity assessment of septic complications in necrotizing pancreatitis. Digestion 1997; 58: 11.